nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2004, 04, 254-256
软药设计
基金项目(Foundation):
邮箱(Email):
DOI: 10.19577/j.cnki.issn10074406.2004.04.028
发布时间: 2004-07-25
出版时间: 2004-07-25
移动端阅读
摘要:

<正>为了提高药物的治疗指数,Bodor等提出和发展了逆代谢药物设计的概念,它包含2种不同的设计策略:软药(soft drug)和化学药物给药系统。软药设计(soft drug design)是将化合物的构效关系(structure-activity relationship,SAR)与构代关系(structure-metabolism relationship,SMR)以及理化性质相结合,目的是设计出更安全的化合物。

关键词:
Abstract:

KeyWords:
参考文献

[1] Bodor N. Retrometabolic drug design-novel aspects, future directions [J]. Pharmazie,2001, 56(Suppl 1): S67.

[2] Bodor N. Recent advances in retrometabolic drug design and targetingapproaches[J]. Pharmazie, 2000, 55(3): 163.

[3] Bodor N. Retrometabolic approaches for drug design and targeting[J].Pharmazie, 1997, 52(7): 491.

[4] Bodor N, Buchwald P. Soft drug design: general principles and recentapplication[J]. Med Res Rev, 2000, 20(1): 58.

[5] Bodor N, Buchwald P. Drug targeting by retrometabolic design: softdrugs and chemical delivery systems[J] . J Recept Signal Transduct Res,2001, 21(2-3): 287.

[6] Bodor N, Buchwald P. Drug targeting via retrometabolic approaches[J].Pharmacol Ther , 1997, 76(1-3): 1.

[7] Satoh T, Hosokawa M. The mammalian carbxylesterases: from molecules to frunctions[J]. Annu Rev Pharmacol Toricol,1998, 38: 257.

[8] Brouillette G, Kawamura M, Kumar GN, et al. Soft drugs. 21. Designand evaluation of soft analogs of propantheline[J]. J Pharm Sci, 1996,85(6): 619.

[9] Huang F, Juhasz A, Wu W, et al. Design, synthesis, and pharmacological evaluation of soft glycopyrrolate and its analog[J]. Pharmazie,2000, 55(3): 187.

[10] Buchwald A, Derendorf H, Ji F, et al. Soft cannabinoid analogues as potential anti-glaucoma agents[J]. Pharmazie, 2002, 57(2): 108.

[11] Ji F, Wu WM, Bodor N. Studies on a soft glycopyrrolate analog, SG 1[J]. Pharmazie, 2002, 57(2): 138.

[12] Yang HS, Wu WM, Bodor N. Soft drugs. XX. Design, syntheis, and evaluation of ultra-short acting beta-blockers[J]. Pharm Res, 1995, 12 (3): 329.

[13] Little RJ, Bodor N, Loftsson T. Soft drugs on hydrocortisone:the inactive metabolite approach and its application to steroidal anti-inflammatory agents[J]. Pharm Res, 1999, 16(6): 961.

[14] Hwang SK, Juhasz A, Yoon SH, et al. Soft drugs. 12. Design, synthesis, and evaluation of soft bufuralol analogues[J]. J Med Chem, 2000,43(8): 1525.

基本信息:

DOI:10.19577/j.cnki.issn10074406.2004.04.028

中图分类号:R914.2

引用信息:

[1]陈燕,郝敬来,仇缀百.软药设计[J].中国临床药学杂志,2004(04):254-256.DOI:10.19577/j.cnki.issn10074406.2004.04.028.

发布时间:

2004-07-25

出版时间:

2004-07-25

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文